Sudhir Saxena is Chief Technology Officer of GNQ Insilico, Inc., a precision medicine TechBio company. Sudhir brings 25+ years of leadership building Product Strategy-through-Deployment organizations, with deep domain expertise across Healthcare and Life Sciences. Across his career as both an entrepreneur and an executive at top-tier consulting firms, he has built and scaled AI-driven Healthcare and Life Sciences platforms, taking them from ideas/concepts to commercial products. At GNQ he currently focuses on building out the GNQ flagship platform with Q-BRM, the company's Quantum infused Biological Reasoning Model, designed to move beyond correlation-based AI by reasoning across associative, interventional, and counterfactual levels of causal inference — work that recently surfaced previously unrecognized drug response mechanisms in oncology. He speaks frequently on causal AI, quantum computing, and the future of genomic medicine